Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Nov;86(3):609–617. doi: 10.1111/j.1476-5381.1985.tb08937.x

Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.

J W Black, N P Shankley
PMCID: PMC1916727  PMID: 2415197

Abstract

In view of the recent M1 and M2 subclassification of muscarinic receptors and the suggestion of separate populations of muscarinic receptors on oxyntic and histamine cells in the gastric mucosa, we have analysed the effects of McN-A 343, classified as an M1-selective agonist, on gastric acid secretion by the mouse, isolated, lumen-perfused stomach assay. Acid secretion stimulated by McN-A 343 was not inhibited by tetrodotoxin pretreatment, although it was competitively antagonized by atropine (pKB 7.90), suggesting a muscarinic site of action between postganglionic neurones and the final secretory event. Acid secretion stimulated by McN-A 343 was more sensitive than 5-methylfurmethide-stimulated secretion to H2-receptor blockade: the profile of inhibition was consistent with expectations for a model of indirect agonism, suggesting that McN-A 343 preferentially stimulated the release of endogenous histamine from mucosal histamine cells. In view of this selective action the McN-A 343-pirenzepine interaction was studied, the latter being classified as an M1-selective antagonist. Results were consistent with expectations for a competitive interaction but the pKB (6.69) was not significantly different from the value obtained at the oxyntic cell, using 5-methylfurmethide as agonist in the presence of H2-receptor blockade, in a previous study. We suggest that there is no need to postulate differences in oxyntic and histamine cell muscarinic receptors to account for the selective stimulant activity of McN-A 343 observed in this study and the relatively selective inhibition of gastric acid secretion by pirenzepine in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A., Black J. W. Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse. Br J Pharmacol. 1979 Sep;67(1):59–65. [PMC free article] [PubMed] [Google Scholar]
  2. Angus J. A., Black J. W. The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Eur J Pharmacol. 1982 May 21;80(2-3):217–224. doi: 10.1016/0014-2999(82)90057-7. [DOI] [PubMed] [Google Scholar]
  3. Berglindh T. Effects of common inhibitors of gastric acid secretion on secretagogue-induced respiration and aminopyrine accumulation in isolated gastric glands. Biochim Biophys Acta. 1977 Jan 4;464(1):217–233. doi: 10.1016/0005-2736(77)90383-2. [DOI] [PubMed] [Google Scholar]
  4. Black J. W., Leff P. Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141–162. doi: 10.1098/rspb.1983.0093. [DOI] [PubMed] [Google Scholar]
  5. Black J. W., Leff P., Shankley N. P. Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol. 1985 Nov;86(3):581–587. doi: 10.1111/j.1476-5381.1985.tb08934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Black J. W., Leff P., Shankley N. P. Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol. 1985 Nov;86(3):589–599. doi: 10.1111/j.1476-5381.1985.tb08935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Black J. W., Shankley N. P. Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol. 1985 Nov;86(3):601–607. doi: 10.1111/j.1476-5381.1985.tb08936.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Black J. W., Shankley N. P. The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br J Pharmacol. 1985 Nov;86(3):571–579. doi: 10.1111/j.1476-5381.1985.tb08933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ecknauer R., Dial E., Thompson W. J., Johnson L. R., Rosenfeld G. C. Isolated rat gastric parietal cells: cholinergic response and pharmacology. Life Sci. 1981 Feb 9;28(6):609–621. doi: 10.1016/0024-3205(81)90124-7. [DOI] [PubMed] [Google Scholar]
  10. Ecknauer R., Thompson W. J., Johnson L. R., Rosenfeld G. C. Isolated parietal cells: [3H]QNB binding to putative cholinergic receptors. Am J Physiol. 1980 Sep;239(3):G204–G209. doi: 10.1152/ajpgi.1980.239.3.G204. [DOI] [PubMed] [Google Scholar]
  11. Kenakin T. P., Beek D. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J Pharmacol Exp Ther. 1980 May;213(2):406–413. [PubMed] [Google Scholar]
  12. Leff P., Martin G. R., Morse J. M. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br J Pharmacol. 1985 Jul;85(3):655–663. doi: 10.1111/j.1476-5381.1985.tb10561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Odori Y., Magee D. F. The action of some agents active at autonomic ganglionic sites on the secretory response of the Heidenhain pouch to various stimuli. Eur J Pharmacol. 1969 Nov;8(2):221–227. doi: 10.1016/0014-2999(69)90080-6. [DOI] [PubMed] [Google Scholar]
  14. ROSZKOWSKI A. P. An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther. 1961 May;132:156–170. [PubMed] [Google Scholar]
  15. Scholes P., Cooper A., Jones D., Major J., Walters M., Wilde C. Characterization of an adenylate cyclase system sensitive to histamine H2-receptor excitation in cells from dog gastric mucosa. Agents Actions. 1976 Nov;6(6):677–682. doi: 10.1007/BF02026087. [DOI] [PubMed] [Google Scholar]
  16. Soll A. H. Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol. 1980 Apr;238(4):G366–G375. doi: 10.1152/ajpgi.1980.238.4.G366. [DOI] [PubMed] [Google Scholar]
  17. Tepperman B. L., Schofield B., Tepperman F. S. Effect of metiamide on acid secretion from isolated kitten fundic mucosa. Can J Physiol Pharmacol. 1975 Dec;53(6):1141–1146. doi: 10.1139/y75-159. [DOI] [PubMed] [Google Scholar]
  18. Wastek G. J., Yamamura H. I. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease. Mol Pharmacol. 1978 Sep;14(5):768–780. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES